Home » Posts tagged 'VLG'

Tag Archives: VLG

Alan Green talks about #VLG Venture Life Group, #POLB Poolbeg Pharma & #WOSG Watches of Switzerland on the Vox Market Podcasts

vox podcast

Alan Green talks about #VLG Venture Life Group, #POLB Poolbeg Pharma & #WOSG Watches of Switzerland on the Vox Market Podcasts

Listen to the Podcast here

Andrew Hore – Quoted Micro 16 August 2021

AQUIS STOCK EXCHANGE

Yooma Wellness Inc (YOOM) has a dual quotation on the Canadian Securities Exchange and obtaining the Aquis quotation is part of the stated strategy to become the largest CBD business in the world. Acquisitions have been made this year and at least three more are lined up. Prior to joining Aquis, Yooma raised £7.46m at 52.32p a share. As well as the cash raised in the placing, there is an option granted to a strategic investor to subscribe £5m for 9.56 million shares. Administrative delays relating to the investor mean that the share issue has not been completed yet. Yooma Wellness says that annualised 2021 sales could be $32m if it makes the expected acquisitions.

Ecotricity has posted its offer document for Good Energy (GOOD), which continues to reject the approach.

Clean Invest Africa (CIA) is in discussions with a potential investor. A fundraising could be secured within weeks. There are also discussions concerning a joint venture. CIA has been hit by Covid-19 measures in South Africa.

Pioneer Media Holdings Inc (PNER) has made an additional investment in connected gaming platform developer Paidia eSports Inc and a new £200,000 investment in Streaks Gaming. Pioneer will own 40% of Paidia. London-based Streaks operates a conversational gaming platform. Users are matched with a personalised digital conversational partner generated by AI. Pioneer will own 16.1% of Streaks.

Sativa Wellness Group Inc (SWEL) increased revenues by 828% in the second quarter of 2021. Revenues in the six months to June 2021, revenues jumped from £733,000 to £4.86m, while the loss reduced from £2.37m to £1.27m. The business is being restructured into three divisions: Goodbody Botanicals, Phytovista and Goodbody Wellness.

Construction of the DJT Plants medical cannabis growing facility started on 4 July. Ananda Investments (ANA) continues to make progress with the purchase of the 50% of DJT it does not own.

Rutherford Health (RUTH) is partnering with genomic and theranostic company OncoDNA, which will enable its patients to obtain genomic testing that can help to secure the most appropriate cancer treatment.

Administrators have been appointed to NQ Minerals (NQMI).

Chris Akers has increased his stake in Oscillate (MUSH) from 3.1% to 9%. Thomas Grant Nominees owns 9.95%. Robert Johnson has a 3% stake in TECC Capital (TEC).

AIM

Drug developer BiVictriX Therapeutics (BVX) has a low capital cost model which outsources the main operations. It has a lead asset called BVX001, which is targeting adult leukaemia. BVX001 has already indicated an anti-tumour effect in animal models. No adverse effects were observed. The £7.5m raised at 20p a share will accelerate the optimisation of BVX001, so it reaches pre-clinical milestones. The share price ended the week at 23.5p.

Marlowe (MRL) has decided not to bid for Restore (RST), which has acquired PRM Green Technologies, which is an IT recycling business. This acquisition will be immediately earnings enhancing.

Crestchic revenues increased by 44% in the first half of 2021 and Northbridge Industrial Services (NBI) group revenues are 22% ahead at £19.6m. The 2021 pre-tax profit forecast was increased from £2.1m to £2.5m.

Self-storage sites operator Lok’nStore (LOK) is increasing occupancy rates and adding new sites. Self-storage revenues increased by 21% over the year to July 2021, which is well ahead of forecasts. The first half growth rate was 11%. Over the 12-month period, occupancy rates have increased from 69.6% to 85.8%.

Oil and gas producer Southern Energy Corp (SOUC) concentrates on areas with proven low-cost producing assets, with the current focus in Mississippi. The strategy is to grow production through acquisitions. Alberta-based Southern Energy plans to increase production to 25,000 barrels of oil per day over the next two year. This will require larger acquisitions than in the past. No cash was raised, and the shares will continue to be traded on the TSX Venture Exchange. The share price opened at 6.5p on the first day and stayed at that level until the end of the second day when it fell to 5p (4p/6p) and that price was maintained.

Science Group (SAG) has made a bid approach for TP Group (TPG). Science group has acquired a 10.2% stake in TPG, with the shares being acquired for 5p each.

Best of the Best (BOTB) says that there has been a 15% decline average weekly sales of competition entries. finnCap has cut its earnings forecast from 142.4p a share to 53.3p a share. There should still be £12m in cash at the end of April 2022.

Venture Life Group (VLG) says interim revenues were lower this year because of the lack of hand sanitiser sales and lower sales of Dentyl in China. Sales of other products grew. Forecasts have been updated for recent acquisitions. Share issues mean that earnings are expected to be flat at 2.5p a share. The full benefits of the acquisitions will come through in 2022 when earnings are expected to be 4.6p a share.

Verditek (VDTK) has raised £353,000 from its Crowd for Angels bond offering.

MAIN MARKET

Foams manufacturer Zotefoams (ZTF) improved its interim pre-tax profit by 49% to £4m even though it was reduced by currency movements. Footwear generates one-third of revenues. The new manufacturing site in Poland has opened.

Argo Blockchain (ARB) generated revenues of £31.1m from mining 883 bitcoin in the first half of 2021. Although revenues are improving, there will be higher than expected tax and finance charges this year. finnCap has reduced its 2021 earnings estimate from 7.6p a share to 5.6p a share.

Plaza Centers NV (PLAZ) has received a revised proposal from GC Hevron Capital. The company’s assets would be transferred to a trustee of managed for the benefit of bondholders. Hevron would be issued shares equivalent to 74.99% of the enlarged share capital. There will be a NIS 2 million payment to cover creditors. Hevron will then inject a new business, which is part of its investment portfolio, into the shell. The target is a nutritional food technology company.

Danakali (DNK) is cancelling its standard listing on 24 September and retaining its ASX listing.

Mast Energy Developments (MAST) has acquired Pyebridge Power, which owns a 9MW gas-powered standby generation facility, for £2.5m in cash. The site could generate EBITDA of £488,000 a year.

Hawkwing (HNG) is raising £16.5m through the issue of 8% convertible loan notes. They are convertible at 6p a share. The cash will be loaned to ecommerce aggregator Internet Fusion Group to finance two acquisitions – an outdoor lifestyle brand and an online fashion accessories retailer. Hawkwing plans to acquire Internet Fusion for an enterprise value of £115m through an issue of shares at 6p each. Trading in Hawkwing shares remains suspended.

Path Investments (PATH) has agreed to acquire DG Innovate for £32m in shares at 0.6p each. DG is developing electric motor technologies and energy storage systems. There is enhanced drive technology, which is being used to develop lightweight and cost-effective electric motors, and enhanced battery technology, which is developing fully-recyclable, sodium-ion batteries offering greater energy density than current technologies.

Andrew Hore

Alan Green talks Venture Life Group #VLG, Hemogenyx #HEMO & Gfinity #GFIN on Vox Markets podcast

Alan Green discusses Venture Life Group #VLG, Hemogenyx #HMO & Gfinity #GFIN with Justin Waite on the Vox Markets podcast. Interview is 13 mins in

Venture Life Group #VLG publishes trading update & reports FY profits ahead of market expectations

Venture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the self-care market, announces its unaudited trading update for the year ended 31st December 2020, ahead of the announcement of the Group’s audited results on 25th March 2021.

The Company expects to report revenues for the year ended 31st December 2020 of £30.1 million, 49% higher than for 2019, and adjusted* EBITDA is expected to be not less than £6 million, more than double the 2019 adjusted EBITDA. There were no further shipments of product to our Chinese oral care partner in H2, but shipments are due to resume in H1 2021.

Despite the challenges presented by the COVID-19 pandemic, revenues across the business grew significantly in 2020, notably in sales of the VLG Brands, which now represent 50% of revenues, compared to 33% in 2019. The significantly increased revenues and higher prevalence of revenues from the VLG Brands in the year have contributed to improving gross margin, as expected. Revenues from the newly acquired PharmaSource business were ahead of 2019, and a number of planned synergies have already been achieved.

The clinical study at Cardiff University on our mouthwashes is still on-going and we will update the market when the results have been published in due course.

Jerry Randall, CEO of Venture Life, commented: “I am delighted to update the market on the delivery of strong growth during 2020. It has been a particularly challenging year for everyone, but the team at Venture Life performed exceptionally well to ensure that the business continued to operate and meet customer requirements. The placing and open offer completed in December 2020 has given us substantial funds, leaving us with net cash (excluding finance lease liabilities) of £35.5m as at the year end,  with which we can now pursue our ambitious acquisition growth and, with an order book ahead of the same time last year, I look forward to updating the market further as we go through the year. “

*Adjusted EBITDA is EBITDA before deduction of exceptional items and share based payments

This announcement contains price sensitive information.

For further information, please contact:

Venture Life Group PLC

+44 (0) 1344 578004

Jerry Randall, Chief Executive Officer

Cenkos Securities plc (Nomad and Joint Broker)

+44 (0) 20 7397 8900

Michael Johnson / Russell Kerr (Sales)

Stephen Keys / Camilla Hume (Corporate Finance)

N+1 Singer (Joint Broker)

+44 (0) 20 7496 3000

Jonathan Dighe (Sales)

Shaun Dobson / Carlo Spingardi (Corporate Finance)

About Venture Life (www.venture-life.com)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands these are supplied direct by the company to retailers, elsewhere they are supplied by the Group’s international distribution partners.

Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

Alan Green talks Versarien #VRS, Venture Life Group #VLG & Bidstack #BIDS on Vox Markets podcast

Alan Green discusses Versarien #VRS, Venture Life Group #VLG & Bidstack #BIDS with Justin Waite on the Vox Markets podcast. Interview is 8 minutes 38 seconds in.

Alan Green presents the investment case for Katoro Gold #KAT and Venture Life Group #VLG on his weekly Stockbox Media Research talk

Alan Green presents the investment case for Katoro Gold #KAT and Venture Life Group #VLG on his weekly Stockbox Media Research talk

Alan Green talks markets, Power Metal Resources #POW, Itaconix #ITX & Venture Life Grp #VLG on the UK Investor Magazine podcast

FTSE 100: The influences of vaccines and Brexit on London’s leading index

Alan Green talks markets, Power Metal Resources #POW, Itaconix #ITX & Venture Life Grp #VLG with Jonathan Roy on the UK Investor Magazine podcast

Alan Green presents the investment case for Synairgen #SNG, Omega Diagnostics #ODX, Open Orphan #ORPH & Venture Life #VLG on his weekly Stockbox Media Research talk

Alan Green presents the investment case for Synairgen #SNG, Omega Diagnostics #ODX, Open Orphan #ORPH & Venture Life #VLG on his weekly Stockbox Media Research talk.

Alan Green talks to Venture Life Group #VLG CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University.

Alan Green talks to Venture Life Group (AIM: VLG) CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University. Sharon also discusses the group progress to date in 2020, and summarises the current investment proposition for investors

Alan Green talks Venture Life Group #VLG, RA International #RAI & Arkle Resources #ARK on Vox Markets podcast

Alan Green discusses Venture Life Group #VLG, RA International #RAI & Arkle Resources #ARK on Vox Markets podcast. Interview is 14 minutes 45 seconds in.

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.